Third ultrasound diagnosis product for osteoporosis approved
This article was originally published in Clinica
Executive Summary
Lunar has been given the go-ahead from the FDA to sell its ultrasound device for measuring bone density at the heel and predicting the risk of osteoporosis-related fractures. The company, of Madison, Wisconsin, has been selling the Achilles+ device outside the US since 1992.